Charles Rudin

131PUBLICATIONS
917CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersGenomics and transcriptomicsTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (131)

|Sep 24, 2026
Senescence-directed nanotherapy ameliorates fibrosis and overcomes immune exclusion in cancer.

|Jul 16, 2026
Durvalumab With Radiation Therapy in Patients With Inoperable Locally Advanced Non-Small Cell Lung Cancer Ineligible for Concurrent Chemoradiotherapy (DART).

|Jun 24, 2026
The Genomic Landscape of MYC-, MYCL-, and MYCN-Amplified Solid Tumors.

|Jun 22, 2026
SMARCA4, STK11, and KEAP1 co-inactivation associates with poor prognosis and upregulation of the TGF-β pathway in lung adenocarcinoma.

|Jun 18, 2026
L1CAM signaling through planar cell polarity drives SOX2 expression and lung adenocarcinoma metastasis.

|Jun 17, 2026
Clinicogenomic analysis of EGFR-mutant lung tumors identifies Rb pathway inactivation as a hallmark of squamous transformation.

Pageof 22

Frequent Collaborators

19 joint publications

John T Poirier

15 joint publications

Natasha Rekhtman

13 joint publications

Bob T Li

13 joint publications

Michael Offin